Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
31%
ALSO IN XPH
XPH
55
HOLDINGS
30%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
VIATRIS, INC. | 4.0% | 2.4% | 2.4% |
|
MERCK & CO. INC. | 8.4% | 2.4% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 7.5% | 2.3% | 2.3% |
|
JOHNSON & JOHNSON | 8.0% | 2.2% | 2.2% |
 |
JAZZ PHARMACEUTICALS PLC | 2.5% | 2.1% | 2.1% |
FTXH Overweight Relative to XPH
|
ABBVIE INC | 6.3% |
|
MERCK & CO. INC. | 6.0% |
|
JOHNSON & JOHNSON | 5.8% |
|
BRISTOL-MYERS SQUIBB CO | 5.3% |
|
CARDINAL HEALTH INC | 4.4% |
|
PFIZER INC | 4.4% |
|
BIOGEN IDEC INC | 4.1% |
|
AMGEN INC | 3.8% |
|
REGENERON PHARMACEUTICALS | 3.8% |
|
GILEAD SCIENCES INC | 3.8% |
FTXH Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.6% |
|
EDGEWISE THERAPEUTICS, INC. | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.4% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
INNOVIVA, INC. | -2.1% |
|
AXSOME THERAPEUTICS, INC. | -2.0% |
|
HARROW INC | -2.0% |
|
EYEPOINT PHARMACEUTICALS INC | -1.9% |